Back to search

Article

Serum proteomics analysis from rheumatoid arthritis patients receiving combination therapy of imrecoxib, total glucosides of paeony and two DMARDs

2022-03-07

Abstract excerpt

<h4>Background: </h4> : Rheumatoid arthritis (RA) is a chronic autoimmune disease. Imrecoxib, disease-modifying anti-rheumatic drugs (DMARDs) and total glucosides of paeony (TGPs) are common clinical therapies for RA. However, the exact mechanism of combination therapy for rheumatoid arthritis is still unclear. This study aims to explore the potential mechanism of this combination therapy for RA. <h4>Methods: </h4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19bc56da-5df1-582b-b46f-bb4acfed724f
DOI
10.21203/rs.3.rs-1421264/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Serum proteomics analysis from rheumatoid arthritis patients receiving combination therapy of imrecoxib, total glucosides of paeony and two DMARDsDOI 10.21203/rs.3.rs-1421264/v1
Select a neighboring publication to make it the new centre.